Role of reactive oxygen species (ROS) in Mycobacterium bovis bacillus Calmette Guérin-mediated up-regulation of the human cathelicidin LL-37 in A549 cells.
Méndez-Samperio. Patricia P; Pérez. Aline A; Torres. Laura L
Key Findings
- BCG infection of A549 lung cells causes rapid ROS production.
- ROS generated via NADPH oxidase (not xanthine oxidase) is essential for up‑regulating LL‑37 mRNA and protein.
- Antioxidants (N‑acetyl‑cysteine, catalase) and NADPH‑oxidase inhibitors (DPI, apocynin) suppress the BCG‑induced LL‑37 response.
Practical Outcomes
- For biohackers interested in boosting innate immunity, this suggests that taking strong antioxidants around the time of an immune challenge (e.g., BCG vaccination or infection) could blunt the natural rise of LL‑37, a key antimicrobial peptide. Timing antioxidant use—perhaps avoiding high doses immediately before or during such challenges—might preserve the ROS‑driven immune boost. However, the study does not provide a direct supplement protocol or dosage guidance.
Summary
When human lung cells are exposed to the BCG vaccine, they quickly produce reactive oxygen species (ROS). This ROS burst is needed for the cells to turn on the antimicrobial peptide LL‑37. Blocking ROS with antioxidants or NADPH‑oxidase inhibitors stops the LL‑37 increase.
Abstract
The human cathelicidin LL-37 is one of the major antimicrobial peptides of the non-specific innate immune system in Mycobacterium tuberculosis infection. Its expression has been reported in epithelial cells infected with mycobacteria. However, the underlying molecular mechanisms by which Mycobacterium bovis bacillus Calmette-Guérin (BCG) triggers gene transcription of cathelicidin have not been elucidated. The objective of this study was to investigate the role of reactive oxygen species (ROS) in the M. bovis BCG-mediated up-regulation of the antimicrobial peptide cathelicidin LL-37 in human epithelial cells. Infection of A549 cells with M. bovis BCG led to a rapid ROS production. Importantly, blockade of ROS by preincubation of cells with the general ROS scavenger N-acetyl-l-cysteine (NAC) or the NADPH oxidase inhibitor DPI significantly reduced M. bovis BCG-induced up-regulation of cathelicidin LL-37 mRNA expression as determined by semi-quantitative RT-PCR or real-time PCR. In contrast, the xanthine oxidase inhibitor allopurinol did not affect M. bovis BCG-mediated up-regulation of cathelicidin LL-37 mRNA. Moreover, M. bovis BCG-mediated cathelicidin LL-37 mRNA expression was significantly blocked by the effect of the mitochondrial electron transfer chain subunit I inhibitor rotenone and H(2)O(2) scavenging enzyme catalase. In addition, M. bovis BCG-induced cathelicidin LL-37 protein secretion was inhibited by the addition of NAC, DPI, and the selective inhibitor of NADPH oxidase apocynin. Our results collectively indicate that M. bovis BCG-mediated up-regulation of cathelicidin is influenced by NADPH/ROS signaling pathways. In conclusion, these findings demonstrate a novel regulatory mechanism for the expression of cathelicidin LL-37 in human epithelial cells stimulated with M. bovis BCG.
Study Information
pubmed
2009
2009-09-01T00:00:00.000Z
10.1016/j.micpath.2009.08.006
26
40